DMAAR
Drugs Made In America Acquisition Corp. RightsDMAAR
DMAAR
0
Funds holding %
of 7,202 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
Research analyst outlook
We haven’t received any recent analyst ratings for DMAAR.
Financial journalist opinion
We haven’t received any recent news articles for DMAAR.
Charts implemented using Lightweight Charts™